Mike joined Horizon in October 2016 as part of the Raptor Pharmaceutical Corp. acquisition. He brings more than 37 years of experience in pharmaceutical development and prior to joining Horizon, he served as senior vice president of technical operations at Raptor, where he was responsible for quality, manufacturing, supply chain and pharmaceutical development.  From July 2004 to March 2015, Mike served in various positions including senior vice president of product development at Jazz Pharmaceuticals plc. In addition, he was responsible for manufacturing, supply chain program management, and technical development in addition to leading the chemistry manufacturing and controls (CMC) diligence for Jazz’s acquisitions of Orphan Medical Inc., Azur Pharma Ltd, EUSA Pharma, and Gentium SpA.

Mike joined Horizon in October 2016 as part of the Raptor Pharmaceutical Corp. acquisition. He brings more than 37 years of experience in pharmaceutical development and prior to joining Horizon, he served as senior vice president of technical operations at Raptor, where he was responsible for quality, manufacturing, supply chain and pharmaceutical development.  From July 2004 to March 2015, Mike served in various positions including senior vice president of product development at Jazz Pharmaceuticals plc. In addition, he was responsible for manufacturing, supply chain program management, and technical development in addition to leading the chemistry manufacturing and controls (CMC) diligence for Jazz’s acquisitions of Orphan Medical Inc., Azur Pharma Ltd, EUSA Pharma, and Gentium SpA.